| Zhang, Bo |
NCT06282796: Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy |
|
|
| Recruiting | N/A | 600 | RoW | Echocardiography | First Hospital of China Medical University | Breast Cancer | 12/26 | 12/28 | | |
NCT06229197: Billroth II With Braun Anastomosis After Radical Distal Gastrectomy for Gastric Cancer |
|
|
| Not yet recruiting | N/A | 176 | NA | Billroth II reconstruction, Braun Anastomosis | Sichuan University | Gastric Cancer, Surgery, Anastomosis, Gastrostomy | 12/26 | 12/27 | | |
NCT06365502: Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial) |
|
|
| Recruiting | N/A | 1860 | RoW | Drug-coated balloon, Guideline-directed medical treatment | Harbin Medical University, Shanghai Shenqi Medical Technology Co., Ltd | Acute Coronary Syndrome (ACS) | 12/27 | 12/30 | | |
NCT06455644: Accuracy of LAA Occluder Size Selection: CT vs. DSA During Combined AF Ablation and LAA Occlusion |
|
|
| Recruiting | N/A | 238 | RoW | CT group, DSA group | First Affiliated Hospital of Shantou University Medical College | Atrial Fibrillation, Arrhythmias, Cardiac, Heart Diseases, Cardiovascular Diseases | 10/26 | 07/31 | | |
NCT05649488: Evaluate the Safety and Efficacy of Intracoronary Lithotripsy Balloon Catheter and Intracoronary Lithotripsy Apparatus |
|
|
| Recruiting | N/A | 184 | RoW | Intracoronary lithotripsy balloon catheter and Intracoronary lithotripsy apparatus, Dragonfly Opstar Imaging Catheter | Shanghai Bluesail Boyuan Medical Technology Co., Ltd. | Coronary Artery Disease, Intravascular Lithotripsy | 12/24 | 09/25 | | |
NCT05409482: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma |
|
|
| Recruiting | N/A | 300 | RoW | | Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Hepatocellular Carcinoma | 03/26 | 03/26 | | |
BEST-BAO, NCT05631847: Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke |
|
|
| Recruiting | N/A | 336 | RoW | Endovascular treatment, Intravenous thrombolysis (Alteplase) | Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital | Acute Ischemic Stroke, Basilar Artery Occlusion, Thrombosis, Alteplase, Endovascular Treatment | 01/27 | 05/27 | | |
| Lin, Feng |
NCT05182463: Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients |
|
|
| Recruiting | 4 | 5000 | RoW | Peginterferon Alfa-2B, Nucleoside Analogs | Third Affiliated Hospital, Sun Yat-Sen University | Hepatitis B, Chronic | 12/26 | 11/29 | | |
NCT05395416: Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C |
|
|
| Recruiting | 2/3 | 520 | RoW | HEC74647PA+HEC110114, Antaitavir Hasophate+Yiqibuvir, Placebo | Sunshine Lake Pharma Co., Ltd. | Chronic HCV Infection | 04/23 | 04/23 | | |
NCT04147208: Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection |
|
|
| Completed | 2 | 250 | RoW | GLS4, Morphothiadine Mesilate Capsules, RTV, Ritonavir tablet, ETV, Entecavir table | Sunshine Lake Pharma Co., Ltd. | Chronic HBV Infection | 06/22 | 09/23 | | |
| Recruiting | 2 | 114 | US | RFB, VSOP, IR | University of Rochester, Stanford University | Mild Cognitive Impairment, Healthy Aging | 02/26 | 02/26 | | |
NCT05970666: Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocellular Carcinoma |
|
|
| Recruiting | 2 | 71 | RoW | TACE with adebrelimab and bevacizumab | The First Affiliated Hospital of Xiamen University, Jiangsu HengRui Medicine Co., Ltd. | Adebrelimab, Hepatocellular Carcinoma, Transformation, Bevacizumab, TACE | 11/26 | 11/26 | | |
NCT03108794: A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B |
|
|
| Recruiting | N/A | 200000 | RoW | | Beijing Friendship Hospital, Beijing YouAn Hospital, The First Hospital of Jilin University, Henan Provincial People's Hospital, Beijing Ditan Hospital, First Affiliated Hospital of Xinjiang Medical University, LanZhou University, The Second Affiliated Hospital of Chongqing Medical University, West China Hospital, Taiyuan No.3 Hospital, Hebei Medical University Third Hospital, Shengjing Hospital, Tianjin Third Central Hospital, Peking University First Hospital, Peking Union Medical College Hospital, The Affiliated Hospital Of Southwest Medical University, Shanghai Public Health Clinical Center, Ruijin Hospital, First Affiliated Hospital Xi'an Jiaotong University, Xiangya Hospital of Central South University, Beijing Tiantan Hospital, Wuhan University, The First Affiliated Hospital of Kunming Medical College, The Affiliated Hospital of Xuzhou Medical University, The Affiliated Hospital of Yanbian University, First Affiliated Hospital of Chongqing Medical University, The Fouth Hospital of Qinghai province, Weifang Medical University, Hunan Provincial People's Hospital, The Second Hospital of Hebei Medical University, Xixi Hospital of Hangzhou, General Hospital of Ningxia Medical University, Union Hospital,Tong Ji Medical College,Huazhong University of Science and Technology, Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital, Peking University People's Hospital, Nanfang Hospital of Southern Medical University, The Affiliated Hospital Of Guizhou Medical University, Guizhou Provincial People's Hospital, Hainan General Hospital, The Second Hospital of Shandong University, The First Affiliated Hospital of Shanxi Medical University, Fifth Hospital of Shijiazhuang City, Yan'an University Affiliated Hospital, Infectious Disease Hospital of Wuhai, Logistics University of Chinese People's Armed Police Forces, People's Hospital of Changji Hui Autonomous Prefecture，Xinjiang | Chronic Hepatitis B | 12/22 | 12/25 | | |
NCT06096077: Evaluation of Tranexamic Acid for Angiotensin-converting Enzyme Inhibitor-induced Angioedema in the Emergency Department |
|
|
| Completed | N/A | 50 | US | | Methodist Health System | Angioedema | 08/23 | 08/23 | | |
NCT05106725: Wearable Devices and Biomarkers Project (Healthiomics) |
|
|
| Recruiting | N/A | 3500 | US | | CureScience | Brain Cancer, Neurological Disorder, Neurological Cancer | 12/25 | 12/25 | | |
NCT05409482: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma |
|
|
| Recruiting | N/A | 300 | RoW | | Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Hepatocellular Carcinoma | 03/26 | 03/26 | | |
NCT05937178: Real-world Study Optimizing Nucleotide-analogues |
|
|
| Recruiting | N/A | 20000 | RoW | ETV/TAF/TDF/TMF/IFN, ETV/TAF/TDF/TMF | Huashan Hospital, The First Affiliated Hospital of Anhui Medical University, Anhui Provincial Hospital, Beijing YouAn Hospital, Peking University People's Hospital, Peking University First Hospital, Xiamen Hospital of Traditional Chinese Medicine, First Affiliated Hospital of Fujian Medical University, LanZhou University, Third Affiliated Hospital, Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Hainan General Hospital, Hebei Medical University Third Hospital, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Henan Provincial People's Hospital, The Second Affiliated Hospital of Harbin Medical University, Tongji Hospital, Wuhan Union Hospital, China, Renmin Hospital of Wuhan University, Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, the Second Hospital of Nangjing, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The First Affiliated Hospital with Nanjing Medical University, The Affiliated Hospital of Xuzhou Medical University, The First Affiliated Hospital of Nanchang University, Shengjing Hospital, Qingdao Sixth People's Hospital, Shandong Provincial Hospital Affiliated to Shandong First Medical University, The Second Hospital of Shandong University, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, West China Hospital, Tianjin Second People's Hospital, First Affiliated Hospital of Xinjiang Medical University, The First People's Hospital of Yunnan, Shulan (Hangzhou) Hospital, Zhejiang University, Southwest Hospital, China, The Second Affiliated Hospital of Chongqing Medical University, Sichuan Provincial People's Hospital | Hepatitis B, Chronic | 01/29 | 01/29 | | |
| Chen, Jia Ching |
| Completed | 4 | 310 | RoW | Caffeine Citrate 20 MG/1 ML Intravenous Solution [CAFCIT] | Children's Hospital of Chongqing Medical University | Apnea of Prematurity, Caffeine, Weaning Oxygen, Medicine Regimen | 10/23 | 10/23 | | |
NCT02323022: Idarubicin Plus Cytarabine (IA) vs IA Plus Cladribine (IAC) as Induction Regimen to Treat Initially Diagnosed Acute Myeloid Leukemia (AML) |
|
|
| Completed | 3 | 618 | RoW | IAC regimen, IA regimen | The First Affiliated Hospital of Soochow University | Acute Myeloid Leukemia | 01/20 | 01/22 | | |
NCT03719534: Haplo HCT vs Haplo-cord HCT for Patients With AML |
|
|
| Completed | 3 | 134 | RoW | haplo-HCT, haplo-cord HCT | The First Affiliated Hospital of Soochow University, Zhejiang University, The Second People's Hospital of Huai'an, Soochow Hopes Hematology Hospital, Hygeia Suzhou Yongding Hospital | Hematopoietic Stem Cell Transplantation, Haplo-identical Donor, Cord Blood Unit, Acute Myeloid Leukemia | 12/22 | 03/23 | | |
PROSPECT, NCT02518594: A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix |
|
|
| Recruiting | 3 | 630 | US | Vaginal progesterone, Prometrium, Placebo, Arabin Pessary | The George Washington University Biostatistics Center, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Short Cervical Length | 03/25 | 04/25 | | |
| Recruiting | 1/2 | 50 | RoW | CAR T-cell therapy | The First Affiliated Hospital of Soochow University, Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | Acute Lymphoblastic Leukemia With Failed Remission | 12/20 | 12/23 | | |
NCT04686929: Abatacept s.c. for aGVHD Prevention in Haplo-HCT |
|
|
| Recruiting | 1/2 | 29 | RoW | Abatacept s.c. | The First Affiliated Hospital of Soochow University | Abatacept, Acute-graft-versus-host Disease, Haplo-identical HCT, Prevention | 06/23 | 12/23 | | |
NCT03487185: Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy |
|
|
| Recruiting | N/A | 1500 | US | Continuous Positive Airway Pressure, CPAP, Sleep Advice Control | The George Washington University Biostatistics Center, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Heart, Lung, and Blood Institute (NHLBI) | Obstructive Sleep Apnea of Adult, Preeclampsia, Obstetrical Complications | 12/26 | 12/26 | | |
NCT05409482: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma |
|
|
| Recruiting | N/A | 300 | RoW | | Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Hepatocellular Carcinoma | 03/26 | 03/26 | | |
| Xie, Wen |
NCT04201808: Efficacy and Safety of TAF in Patients With Suboptimal Response to Other Nucleos(t)Ides |
|
|
| Recruiting | 4 | 100 | RoW | Tenofovir Alafenamide 25 MG, Vemlidy | New Discovery LLC, Beijing Ditan Hospital | Hepatitis B, Chronic | 09/23 | 09/23 | | |
NCT04939441: Regression of Liver Fibrosis by Tenofovir Alafenamide (TAF) |
|
|
| Active, not recruiting | 4 | 100 | RoW | Tenofovir alafenamide, Vemlidy® | Jidong Jia, Beijing Ditan Hospital, ShuGuang Hospital, Tianjin Third Central Hospital, Huashan Hospital, The Sixth Peoples Hospital of Zhengzhou, Tianjin Second People's Hospital, Ruijin Hospital, Shanghai East Hospital | Chronic Hepatitis B | 05/24 | 05/25 | | |
NATiV3, NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( ) |
|
|
| Recruiting | 3 | 1000 | Europe, Canada, US, RoW | IVA337, Lanifibranor, Placebo | Inventiva Pharma | NASH - Nonalcoholic Steatohepatitis | 09/25 | 09/26 | | |
NCT05905172: Hydroxynidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis |
|
|
| Recruiting | 3 | 248 | RoW | Hydronidone capsules, F351, The placebo capsules, N | Beijing Continent Pharmaceutical Co, Ltd. | Liver Fibrosis | 06/28 | 10/28 | | |
NCT04147208: Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection |
|
|
| Completed | 2 | 250 | RoW | GLS4, Morphothiadine Mesilate Capsules, RTV, Ritonavir tablet, ETV, Entecavir table | Sunshine Lake Pharma Co., Ltd. | Chronic HBV Infection | 06/22 | 09/23 | | |
NCT03131427: China Registry for Genetic / Metabolic Liver Diseases |
|
|
| Recruiting | N/A | 20000 | RoW | Standard of care | Beijing Friendship Hospital, Beijing YouAn Hospital, Henan Provincial People's Hospital, Beijing Ditan Hospital, Hebei Medical University Third Hospital, Peking University First Hospital, Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital, Nanfang Hospital of Southern Medical University, Logistics University of Chinese People's Armed Police Forces, Beijing Anzhen Hospital, West China Second University Hospital of Sichuan University, Jinshan Hospital Fudan University, Fudan University | Genetic/Metabolic Liver Diseases | 04/22 | 04/27 | | |
NCT03108794: A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B |
|
|
| Recruiting | N/A | 200000 | RoW | | Beijing Friendship Hospital, Beijing YouAn Hospital, The First Hospital of Jilin University, Henan Provincial People's Hospital, Beijing Ditan Hospital, First Affiliated Hospital of Xinjiang Medical University, LanZhou University, The Second Affiliated Hospital of Chongqing Medical University, West China Hospital, Taiyuan No.3 Hospital, Hebei Medical University Third Hospital, Shengjing Hospital, Tianjin Third Central Hospital, Peking University First Hospital, Peking Union Medical College Hospital, The Affiliated Hospital Of Southwest Medical University, Shanghai Public Health Clinical Center, Ruijin Hospital, First Affiliated Hospital Xi'an Jiaotong University, Xiangya Hospital of Central South University, Beijing Tiantan Hospital, Wuhan University, The First Affiliated Hospital of Kunming Medical College, The Affiliated Hospital of Xuzhou Medical University, The Affiliated Hospital of Yanbian University, First Affiliated Hospital of Chongqing Medical University, The Fouth Hospital of Qinghai province, Weifang Medical University, Hunan Provincial People's Hospital, The Second Hospital of Hebei Medical University, Xixi Hospital of Hangzhou, General Hospital of Ningxia Medical University, Union Hospital,Tong Ji Medical College,Huazhong University of Science and Technology, Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital, Peking University People's Hospital, Nanfang Hospital of Southern Medical University, The Affiliated Hospital Of Guizhou Medical University, Guizhou Provincial People's Hospital, Hainan General Hospital, The Second Hospital of Shandong University, The First Affiliated Hospital of Shanxi Medical University, Fifth Hospital of Shijiazhuang City, Yan'an University Affiliated Hospital, Infectious Disease Hospital of Wuhai, Logistics University of Chinese People's Armed Police Forces, People's Hospital of Changji Hui Autonomous Prefecture，Xinjiang | Chronic Hepatitis B | 12/22 | 12/25 | | |
| Recruiting | N/A | 240 | RoW | Carvedilol 12.5 MG, Nucleos(t)ide Analogues | Beijing Friendship Hospital | Liver Cirrhosis, Portal Hypertension | 10/24 | 10/24 | | |
NCT05140837: Early Diagnosis and Timely Treatment of Cirrhotic Patients With Minimal Hepatic Encephalopathy (CHESS-NCRCID 2106) |
|
|
| Recruiting | N/A | 10000 | RoW | Psychometric hepatic encephalopathy score & Stroop test, Drug therapy | Hepatopancreatobiliary Surgery Institute of Gansu Province, The First Affiliated Hospital of Anhui Medical University, Beijing Ditan Hospital, Chongqing Public Health Medical Treatment Center, Meng Chao Hepatobiliary Hospital of Fujian Medical University, Guangxi Zhuang Autonomous Region People's Hospital, Shenzhen Third People's Hospital, Guizhou people's Hospital, Wuhan Union Hospital, China, Xiangya Hospital of Central South University, The Second Affiliated Hospital of Hainan Medical University, The Third Affiliated Hospital of Hebei Medical University, The Second Affiliated Hospital of Harbin Medical University, Henan Provincial People's Hospital, Ganzhou Fifth People's Hospital, The First Hospital of Jilin University, Jiangsu People's Hospital, First Hospital of China Medical University, The Second Affiliated Hospital of Baotou Medical College, Ningxia Medical University General Hospital, The Fourth People's Hospital of Qinghai Province, Xi'an High-tech Hospital, The 10th People's Hospital affiliated to Tongji University, Qilu Hospital of Shandong University, The Third People's Hospital of Taiyuan, Xichang People's Hospital, Tianjin Third Central Hospital, The Third People's Hospital of Tibet Autonomous Region, Xinjiang Autonomous Region People's Hospital, Second People's Hospital of Yunnan Province, Hangzhou Xixi hospital, LanZhou University | Hepatic Encephalopathy, Cirrhosis | 12/24 | 12/24 | | |
NCT05409482: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma |
|
|
| Recruiting | N/A | 300 | RoW | | Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Hepatocellular Carcinoma | 03/26 | 03/26 | | |
| Wang, Yong |
| Recruiting | 3 | 1000 | Europe, Canada, US, RoW | Ralinepag, APD811, Placebo | United Therapeutics | PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension, Connective Tissue Diseases, Familial Primary Pulmonary Hypertension, Vascular Diseases, Cardiovascular Diseases, Hypertension, Pulmonary, Lung Diseases, Respiratory Tract Disease | 12/24 | 12/24 | | |
CYCLONE 3, NCT05288166: A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) |
|
|
| Active, not recruiting | 3 | 900 | Europe, Canada, Japan, US, RoW | Abemaciclib, LY2835219, Abiraterone, Prednisone or Prednisolone, Placebo for Abemaciclib | Eli Lilly and Company | Prostatic Neoplasms, Neoplasm Metastasis, Urogenital Neoplasms, Physiological Effects of Drugs, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Androgens, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Abiraterone Acetate, Steroid Synthesis Inhibitors, Cytochrome P-450, Enzyme Inhibitors, Prednisone, Prednisolone, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6 | 02/24 | 10/27 | | |
NCT04691804 / 2020-006063-28: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer |
|
|
| Recruiting | 3 | 804 | Europe, US, RoW | Fuzuloparib , Abiraterone acetate and Prednisone, SHR3162, Fuzuloparib Placebo， Abiraterone acetate and Prednisone | Jiangsu HengRui Medicine Co., Ltd. | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | 12/26 | 12/26 | | |
NCT04848753: Perioperative Toripalimab (JS001) Combined With Neoadjuvant Chemotherapy in Patients With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma |
|
|
| Active, not recruiting | 3 | 663 | RoW | Toripalimab combined with cisplatin and paclitaxel, Placebo combined with cisplatin and paclitaxel | Shanghai Junshi Bioscience Co., Ltd. | Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma | 05/27 | 05/27 | | |
NCT05323201: Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer |
|
|
| Recruiting | 1/2 | 15 | RoW | fhB7H3.CAR-Ts, B7H3 targeting chimeric antigen receptor T cells, Fludarabine, FLUDARA, Cyclophosphamide, Cytoxan | The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, IIT MediTech Co. Ltd | Hepatocellular Carcinoma | 02/24 | 02/27 | | |
CLASS-03a, NCT03468712: Laparoscopic D2 Distal Gastrectomy Following Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancers |
|
|
| Recruiting | N/A | 166 | RoW | Laparoscopic D2 distal gastrectomy | West China Hospital, Peking University Cancer Hospital & Institute, Southern Medical University, China, Shanghai Zhongshan Hospital, Chinese PLA General Hospital, Fujian Medical University Union Hospital, Ruijin Hospital, Southwest Hospital, China, RenJi Hospital, The First Affiliated Hospital with Nanjing Medical University, Fudan University, Tang-Du Hospital, Harbin Medical University, The First Hospital of Jilin University, Guangdong Provincial People's Hospital, Sir Run Run Shaw Hospital | Complications, Postoperative, Surgery--Complications, Cancer of Stomach, Chemotherapy Effect | 04/20 | 04/23 | | |
NCT04835272: Comparison of the Decannulation Protocol With Suctioning and Capping in Severe Acquired Brain Injury Patients |
|
|
| Not yet recruiting | N/A | 104 | RoW | the Decannulation Protocol With Suctioning, the Decannulation Protocol With Capping | Fu Xing Hospital, Capital Medical University | Tracheostomy Decannulation, Acquired Brain Injury | 03/23 | 10/23 | | |
| Recruiting | N/A | 40 | US | Multi-modal, multi-parametric, multiscale imaging of the myofascial unit | Washington University School of Medicine, National Center for Complementary and Integrative Health (NCCIH) | Myofascial Pain | 04/25 | 04/25 | | |
| Recruiting | N/A | 147 | US | STEGA-MRI | Washington University School of Medicine, National Institute of Neurological Disorders and Stroke (NINDS) | Peripheral Nerve Injury Upper Limb, Healthy | 12/25 | 12/25 | | |
NCT05409482: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma |
|
|
| Recruiting | N/A | 300 | RoW | | Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Hepatocellular Carcinoma | 03/26 | 03/26 | | |
NCT05443672: Multi-center Study of Deep Learning AI in Breast Mass |
|
|
| Recruiting | N/A | 1122 | RoW | Yizhun BUSMS | Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing Cancer Hospital, Peking University Third Hospital, Guangdong Provincial Hospital of Traditional Chinese Medicine, Third Affiliated Hospital of Zhengzhou University, Hebei Medical University Fourth Hospital, Henan Cancer Hospital, Shanxi Province Cancer Hospital, First Affiliated Hospital Xi'an Jiaotong University, Chongqing University Cancer Hospital, Anqing Hospital affiliated to Anhui Medical University, Qinhuangdao Maternal and Child Health Care Hospital, The First Affiliated Hospital of Xiamen University, Anyang Tumor Hospital, The Third Affiliated Hospital of Jinzhou Medical University, General Hospital of Jincheng Coal Industry Group, Suzhou First People's Hospital, Peking University | Breast Neoplasms | 08/22 | 08/23 | | |
| Chen, yi shing |
NCT05439629: Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration |
|
|
| Active, not recruiting | 3 | 488 | RoW | BAT5906 injection, Lucentis | Bio-Thera Solutions | Neovascular (Wet) Age-related Macular Degeneration | 04/24 | 06/25 | | |
NCT05634382: Endovascular Thrombectomy With and Without Intravenous Thrombolysis in Extended Time Window |
|
|
| Recruiting | 3 | 222 | RoW | Intravenous thrombolysis agents, endovascular thrombectomy | Second Affiliated Hospital, School of Medicine, Zhejiang University | Stroke, Acute Ischemic | 11/24 | 02/25 | | |
NCT04547049: A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies |
|
|
| Recruiting | 3 | 160 | RoW | Cytarabine, Busulfan, Cyclophosphamide, Me-CCNU, Rabbit antithymocyte globulin, Allogeneic HSCT, Cyclosporin A, Mycophenolate Mofetil, MTX | First Affiliated Hospital of Zhejiang University | Leukemia | 09/25 | 12/25 | | |
NCT05084027: Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT |
|
|
| Recruiting | 2 | 50 | RoW | venetoclax combining with fludarabine and melphalan | First Affiliated Hospital of Zhejiang University, Sir Run Run Shaw Hospital, Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial People's Hospital, The affiliated people's hospital of Ningbo University, First Affiliated Hospital of Wenzhou Medical University, Ningbo Hospital of Zhejiang University, The First Affiliated Hospital of Zhejiang Chinese Medical University | Hematologic Malignancy, Older Patients, Allogeneic Hematopoietic Stem Cell Transplantation | 09/22 | 09/24 | | |
NCT04849351: Clinical Study of HMPL-689 for Relapsed/Refractory Marginal Zone Lymphoma and Follicular Lymphoma |
|
|
| Recruiting | 2 | 185 | RoW | HMPL-689, Phosphatidylinositol 3-kinase-δ inhibitor | Hutchison Medipharma Limited | Marginal Zone Lymphoma, Follicular Lymphoma | 04/24 | 12/24 | | |
| Not yet recruiting | N/A | 60 | RoW | Endostar, S1 | Peking University Third Hospital, Mianyang Central Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing Cancer Hospital, Peking University International Hospital, China-Japan Friendship Hospital, The fifth medical center of PLA general hospital, Second Hospital of Shanxi Medical University, Hiser Medical Center of Qingdao, Guangxi Ruikang Hospital, GEM flower hospital of Liaohe oil field, Tang-Du Hospital, Third Affiliated Hospital of Guizhou Medical University, Liuzhou Worker's Hospital, The Affiliated Hospital of Xuzhou Medical University, Dalian municipal central hospital affiliated of dalian medical university | Radiotherapy Side Effect | 01/22 | 01/23 | | |
NCT05475990: Comparison of Hydroxyethyl Starch and Crystalloid Coload Combined With Norepinephrine Infusion for Hypotension |
|
|
| Completed | N/A | 80 | RoW | Hydroxyethyl starch, Colloid, Crystalloid | General Hospital of Ningxia Medical University | Adverse Effect | 03/23 | 03/23 | | |
NCT05475886: 6% Hydroxyethyl Starch (130/0.4) Coload for Postspinal Anesthesia Hypotension |
|
|
| Recruiting | N/A | 40 | RoW | Hydroxyethyl starch 130/0.4, Colloid | General Hospital of Ningxia Medical University | Adverse Effect | 04/24 | 04/24 | | |
NCT04556370: Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia. |
|
|
| Completed | N/A | 180 | RoW | Normal saline, NS, Norepinephrine, Vasopressors | General Hospital of Ningxia Medical University | Adverse Effect | 06/23 | 06/23 | | |
NCT05690334: Different Crystalloid Coload Volumes on the 90% ED of Norepinephrine |
|
|
| Completed | N/A | 90 | RoW | Crystalloid - 0 ml/kg, Crystalloid, Crystalloid - 5 ml/kg, Crystalloid - 10 ml/kg | General Hospital of Ningxia Medical University | Adverse Effect | 06/23 | 06/23 | | |
NCT05475873: Ondansetron for Postspinal Anesthesia Hypotension |
|
|
| Completed | N/A | 120 | RoW | normal saline, NS, Ondansetron 4 mg, 5-HT3 receptor antagonist, Ondansetron 8 mg | General Hospital of Ningxia Medical University | Adverse Effect | 10/23 | 10/23 | | |
NCT06151483: Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension |
|
|
| Recruiting | N/A | 1200 | RoW | Alpha-Agonist, Vasopressors, α-adrenergic receptor agonist | General Hospital of Ningxia Medical University | Outcome | 12/24 | 12/24 | | |
NCT06151431: Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension in Preeclamptic Patients |
|
|
| Recruiting | N/A | 300 | RoW | Alpha-Agonist, Vasopressors, α-adrenergic receptor agonist | General Hospital of Ningxia Medical University | Adverse Effect | 06/24 | 06/24 | | |
NCT05035485: Maternal Cardiac Output Response to Rescue Norepinephrine and Phenylephrine Boluses in Patients With Severe Preeclampsia |
|
|
| Completed | N/A | 40 | RoW | Phenylephrine, Vasopressors, Norepinephrine | General Hospital of Ningxia Medical University | Hemodynamic Instability | 01/24 | 01/24 | | |
NCT05035498: Prophylactic Norepinephrine and Phenylephrine Infusion for Hemodynamic Effects in Patients With Preeclampsia |
|
|
| Recruiting | N/A | 72 | RoW | Phenylephrine, Vasopressors, Norepinephrine | General Hospital of Ningxia Medical University | Hemodynamic Instability | 04/25 | 04/25 | | |
NCT06233838: Multi-center Clinical Study on Hemoperfusion of KHA80 |
|
|
| Not yet recruiting | N/A | 394 | RoW | KHA80 hemoperfusion treatment | First Affiliated Hospital of Fujian Medical University | Uremia, Uremic Osteodystrophy, Dialysis Related Complication | 07/24 | 02/25 | | |
NCT06276309: Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors |
|
|
| Recruiting | N/A | 300 | RoW | | Fujian Maternity and Child Health Hospital | Neuroendocrine Neoplasm, China, Women, Cervical Cancer, Cervical Lesion | 06/24 | 06/24 | | |
NCT05712018: Comparison of Different HES Coload Volumes on the 90% ED of Norepinephrine |
|
|
| Completed | N/A | 90 | RoW | Hydroxyethyl starch coload - 0 ml/kg, Colloid, Hydroxyethyl starch coload - 5 ml/kg, Hydroxyethyl starch coload - 10 ml/kg | General Hospital of Ningxia Medical University | Adverse Effect | 01/24 | 01/24 | | |
NCT06151444: Intensive Versus Standard Treatment for Hypotension on Maternal Hemodynamics in Preeclamptic Patients |
|
|
| Not yet recruiting | N/A | 160 | NA | Alpha-Agonist, Vasopressors, α-adrenergic receptor agonist | General Hospital of Ningxia Medical University | Adverse Effect | 12/24 | 12/24 | | |
NCT06473818: Non-invasive vs Invasive Cardiac Output Monitoring During Cesarean Section |
|
|
| Not yet recruiting | N/A | 50 | NA | Non-invasive monitoring, Hemodynamics, Invasive monitoring, hemodynamics | General Hospital of Ningxia Medical University | Hemodynamics | 11/24 | 11/24 | | |
NCT05323253: A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma |
|
|
| Recruiting | N/A | 86 | Canada, US, RoW | DaRT seeds, DaRT | Alpha Tau Medical LTD. | Recurrent Squamous Cell Carcinoma | 12/24 | 12/25 | | |
NCT06151509: 90% Effective Dose of Norepinephrine Infusions Under Intensive and Standard Treatment |
|
|
| Not yet recruiting | N/A | 80 | NA | Alpha-Agonist, norepinephrine, α-adrenergic receptor agonist | General Hospital of Ningxia Medical University | Adverse Effect | 03/25 | 03/25 | | |
NCT06151457: 90% Effective Dose of Norepinephrine Infusions Under Intensive and Standard Treatment in Preeclamptic Patients |
|
|
| Not yet recruiting | N/A | 80 | NA | Alpha-Agonist, Norepinephrine, α-adrenergic receptor agonist | General Hospital of Ningxia Medical University | Adverse Effect | 06/25 | 06/25 | | |
NCT06158048: ED90 of Norepinephrine and Phenylephrine Infusions Under Intensive Treatment |
|
|
| Not yet recruiting | N/A | 80 | NA | Norepinephrine, Vasopressor, Phenylephrine | General Hospital of Ningxia Medical University | Adverse Effect | 03/25 | 03/25 | | |
NCT06158022: ED90 of Norepinephrine and Phenylephrine Infusions Under Intensive Treatment in Preeclamptic Patients |
|
|
| Not yet recruiting | N/A | 80 | NA | Norepinephrine, Vasopressor, Phenylephrine | General Hospital of Ningxia Medical University | Adverse Effect | 06/25 | 06/25 | | |
NCT06151522: 90% Effective Dose of Phenylephrine Infusions Under Intensive and Standard Treatment |
|
|
| Not yet recruiting | N/A | 80 | NA | Alpha-Agonist, norepinephrine, α-adrenergic receptor agonist | General Hospital of Ningxia Medical University | Adverse Effect | 06/25 | 06/25 | | |
NCT06158009: ED90 of Norepinephrine and Phenylephrine Boluses Under Intensive Treatment |
|
|
| Not yet recruiting | N/A | 80 | NA | Norepinephrine, Vasopressor, Phenylephrine | General Hospital of Ningxia Medical University | Adverse Effect | 06/25 | 06/25 | | |
NCT05355675: The Association of Microbiota Composition With cGVHD After Allo-HSCT |
|
|
| Recruiting | N/A | 300 | RoW | blood sample, stool sample | First Affiliated Hospital of Zhejiang University | Hematopoietic Stem Cell Transplantation, Hematologic Malignancy, Chronic Graft-versus-host-disease, Complication | 05/25 | 05/25 | | |
NCT06151470: 90% Effective Dose of Phenylephrine Infusions Under Intensive and Standard Treatment in Preeclamptic Patients |
|
|
| Not yet recruiting | N/A | 80 | NA | Alpha-Agonist, Phenylephrine, α-adrenergic receptor agonist | General Hospital of Ningxia Medical University | Adverse Effect | 12/25 | 12/25 | | |
NCT06158035: ED90 of Norepinephrine and Phenylephrine Boluses Under Intensive Treatment in Preeclamptic Patients |
|
|
| Not yet recruiting | N/A | 80 | NA | Norepinephrine, Vasopressor, Phenylephrine | General Hospital of Ningxia Medical University | Adverse Effect | 12/25 | 12/25 | | |
NCT05409482: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma |
|
|
| Recruiting | N/A | 300 | RoW | | Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Hepatocellular Carcinoma | 03/26 | 03/26 | | |
| Wang, Cong |
NCT05325190: Granisetron Transdermal Patch System for Prevention of CINV by CapeOX |
|
|
| Recruiting | 2 | 57 | RoW | Granisetron Transdermal Patch System, Sancuso® | Tianjin Medical University Cancer Institute and Hospital | Chemotherapy-induced Nausea and Vomiting | 12/22 | 06/23 | | |
NCT05959694: A Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) . |
|
|
| Recruiting | 1/2 | 107 | RoW | TQB3909 tablet | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | 12/25 | 06/26 | | |
NCT05409482: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma |
|
|
| Recruiting | N/A | 300 | RoW | | Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Hepatocellular Carcinoma | 03/26 | 03/26 | | |
| Zhang, Hui |
| Recruiting | 4 | 1500 | RoW | EV71 Vaccine | Institute of Medical Biology, Chinese Academy of Medical Sciences, Shanxi Center for Disease Control and Prevention | Hand, Foot and Mouth Disease | 03/24 | 07/26 | | |
NCT06014190: HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer |
|
|
| Recruiting | 2 | 460 | RoW | HS-20089 | Hansoh BioMedical R&D Company | Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Endometrial Cancer | 12/25 | 12/27 | | |
NCT06308406: A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer |
|
|
| Recruiting | 1/2 | 54 | RoW | Bevacizumab； HRS-1167 | Jiangsu HengRui Medicine Co., Ltd. | Recurrent Ovarian Cancer | 10/25 | 10/25 | | |
NCT05245916: IBI397 or Combination Therapies in Patients With Advanced Malignancies |
|
|
| Withdrawn | 1a/1b | 30 | RoW | IBI397, IBI397+Sintilimab, IBI397+Rituximab | Innovent Biologics (Suzhou) Co. Ltd. | Advanced Malignancies | 08/23 | 08/23 | | |
NCT04556799: The Clinical Results of Derotational Osteotomy Based on 3D Osteotomy Template for Treatment of Recurrent Patellar Dislocation Combined With Patellofemoral Maltracking |
|
|
| Not yet recruiting | N/A | 50 | NA | computer-assisted surgery, traditional osteotomy | Beijing Jishuitan Hospital | Recurrent Patellar Dislocation, Osteotomy, Patellar Maltracking | 06/22 | 06/23 | | |
NCT04556812: Adults Habitual Patellar Dislocation:a Multiple-center Clinical Investigation Regarding Diagnosis and Therapeutic Strategy |
|
|
| Not yet recruiting | N/A | 120 | NA | Four-in-one procedure, soft-tissue surgery | Hui Zhang | Habitual Patellar Dislocation | 06/22 | 06/23 | | |
NCT05943314: Clinical Study on Safety and Efficacy of Anti-CLL1 /+CD33 CAR T Cells in the Treatment of Acute Myeloid Leukemia |
|
|
| Withdrawn | N/A | 5 | RoW | CLL1/+CD33 CAR-T | Guangzhou Bio-gene Technology Co., Ltd | Acute Myeloid Leukemia | 08/23 | 08/23 | | |
NCT06141551: Intradural Disc Herniation: a Case Report and Review of Complications |
|
|
| Active, not recruiting | N/A | 1 | RoW | total laminectomy decompression, posterior approach lumbar spinal fusion | Gansu Provincial Hospital | Disc Herniation | 12/23 | 12/23 | | |
| Recruiting | N/A | 20 | RoW | Eravacycline Injection | Fujian Medical University Union Hospital | Pulmonary Infection, Pneumonia, Bacterial, Acinetobacter Baumannii | 10/24 | 12/24 | | |
NCT06250842: Benzodiazepine Impact on Cognitive Function: fNIRs and PET/MRI Study |
|
|
| Recruiting | N/A | 100 | RoW | | The First Affiliated Hospital of Dalian Medical University | Benzodiazepine Adverse Reaction, Depression, Anxiety, Benzodiazepine Dependence | 02/26 | 06/26 | | |
NCT05409482: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma |
|
|
| Recruiting | N/A | 300 | RoW | | Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Hepatocellular Carcinoma | 03/26 | 03/26 | | |
NCT05569460: Construction of Perioperative Medical Data Platform and Its Typical Practice to Predict Postoperative Acute Moderate to Severe Pain With Machine Learning Models |
|
|
| Recruiting | N/A | 6500 | RoW | No intervention | Guangdong Second Provincial General Hospital | Anesthesia, Acute Pain, Risk Reduction | 10/23 | 12/23 | | |
| Zhang, Zhi Z |
NCT05352516: A Study to Evaluate the Efficacy and Safety of HLX14 vs. Denosumab Prolia® in Postmenopausal Women With Osteoporosis at High Risk of Fracture |
|
|
| Active, not recruiting | 3 | 478 | RoW | HLX14, Prolia® | Shanghai Henlius Biotech | Postmenopausal | 04/24 | 08/24 | | |
| Recruiting | 3 | 516 | RoW | Tirofiban, Tirofiban Hydrochloride and Sodium Chloride Injection, Aspirin tablet, Clopidogrel tablet | Peking Union Medical College Hospital, Pharmaron (Chengdu) Clinical Services Co., Ltd. | Branch Atheromatous Disease | 07/25 | 10/25 | | |
NCT05927779: Study of TFX06 in Women With Advanced Breast Cancer. |
|
|
| Recruiting | 1/2 | 74 | RoW | TFX06 tablet | Shenzhen Yangli Pharmaceutical Technology Co., Ltd | ER+, HER2- Advanced Breast Cancer, Metastatic Breast Cancer | 12/24 | 04/25 | | |
NCT05409482: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma |
|
|
| Recruiting | N/A | 300 | RoW | | Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Hepatocellular Carcinoma | 03/26 | 03/26 | | |
| Huang, Ning |
NCT05409547: A Clinical Study of Autologous Peripheral Blood Stem Cell Mobilization for PEG-G-CSF |
|
|
| Not yet recruiting | 4 | 80 | NA | PEG-rhG-CSF, rhG-CSF | Ning Huang | Granulocyte Colony-stimulating Factor, Stem Cell Mobilization | 04/25 | 04/25 | | |
NCT06010953: SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment |
|
|
| Recruiting | 1/2 | 24 | RoW | SS109 | Jiangsu Gensciences lnc. | Male, Hemophilia A With Inhibitor, Hemophilia B With Inhibitor, Hemophilia | 07/24 | 07/24 | | |
NCT05651061: A Phase I of SS109 in Hemophilia A or and B With Inhibitors |
|
|
| Completed | 1 | 27 | RoW | SS109 | Jiangsu Gensciences lnc. | Hemophilia A With Inhibitor, Hemophilia B With Inhibitor, Factor VII Deficiency | 03/23 | 08/23 | | |
NCT05409482: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma |
|
|
| Recruiting | N/A | 300 | RoW | | Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Hepatocellular Carcinoma | 03/26 | 03/26 | | |
